Login / Signup

Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection.

Chan-Loi YongJoseph C GatheGabriele KnechtCatherine OrrellJosep MallolasDaniel PodzamczerBenoit TrottierWei ZhangJohn P SaboRichard ViniskoMurray DrulakAnne-Marie Quinson
Published in: HIV clinical trials (2018)
These data suggest NVP-XR achieves lower but effective NVP exposure compared with NVP-IR.
Keyphrases
  • physical activity
  • drug delivery
  • electronic health record
  • big data
  • machine learning
  • artificial intelligence